title: The fallopian tube: from back stage to center stage.
abstract: The recognition that a significant fraction of what historically has been classified as ovarian cancer is, in fact, a malignancy that arises in the fallopian tube mucosa comprises a paradigm shift in our understanding of these neoplasms. New etiologic and management opportunities have been created by this insight, both for women at increased genetic risk of ovarian cancer by virtue of being BRCA1/2 mutation carriers and, perhaps, for women in the general population as well.
authors: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. greenem@mail.nih.gov.
authors: Mark H
authors: MH
authors: Greene
authors: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
authors: Phuong L
authors: PL
authors: Mai
mesh_terms: D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000517:prevention & control*; D010051:Ovarian Neoplasms / Q000517:prevention & control*; D065286:Prophylactic Surgical Procedures; D058994:Salpingectomy / Q000706:statistics & numerical data*